GT-1708F

N/A

Report date: 2024/06/14 13:15:51
NME

Base Information

Drug NameGT-1708F
Drug Alias NameGT-1708FGT-1708GT1708F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSmoothened receptor inhibitorsHedgehog cell-signalling pathway inhibitors
TargetsSmoothened receptor
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary FibrosisHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursIdiopathic Pulmonary FibrosisHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A